Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TAZ is a novel oncogene in non-small cell lung cancer.

Oncogene - 5 May 2011

Zhou Z, Hao Y, Liu N, Raptis L, Tsao M-S, Yang X

Abstract excerpt

Transcriptional coactivator with PDZ-binding motif (TAZ) is a transcriptional coactivator involved in the differentiation of stem cell as well as the development of multiple organs. Recently, TAZ has also been identified as a major component of the novel Hippo-LATS tumor suppressor pathway and to function as an oncogene in breast cancer. We show for the first time that TAZ is an oncogene in non-small cell lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Transcription Factors
Share to Acyltransferases
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to DNA Primers

Share to Gene Knockdown Techniques

Share to Lung Neoplasms

Share to Oncogenes

Source

Identifiers

PMID: 21258416
DOI: 10.1038/onc.2010.606

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TAZ is a novel oncogene in non-small cell lung cancer.PMID 21258416Read ↗

Division of labor between YAP and TAZ in non-small cell lung cancerSemantic proximity Read ↗

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancerSemantic proximity Read ↗

YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.Semantic proximity Read ↗

Role of TELO2-interacting protein 1(TTI1) functions as an oncogene by regulating mTOR activity in the progression of non-small cell lung cancerSemantic proximity Read ↗

Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.Semantic proximity Read ↗

Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasisSemantic proximity Read ↗

Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signalingSemantic proximity Read ↗

Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activationSemantic proximity Read ↗

CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1Semantic proximity Read ↗

Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor ProgressionSemantic proximity Read ↗

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells.Semantic proximity Read ↗

Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.